Proton pump inhibitor use and cancer mortality-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proton pump inhibitor use and cancer mortality

Published:2018-05-02 Issue:6 Volume:143 Page:1315-1326
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Tvingsholm Siri A.¹,Dehlendorff Christian²,Østerlind Kell³,Friis Søren²,Jäättelä Marja¹^ORCID

Affiliation:

1. Cell Death and MetabolismCenter for Autophagy, Recycling and Disease, Danish Cancer Society Research CenterCopenhagen Denmark

2. Statistics and PharmocoepidemiologyDanish Cancer Society Research CenterCopenhagen Denmark

3. Department of OncologyRigshospitaletCopenhagen Denmark

Funder

European Research Council

Danish National Research Foundation

Danish Cancer Society

Novo Nordisk UK Research Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31529

Reference37 articles.

1. Proton pump inhibitors: actions and reactions

2. Rising rates of proton pump inhibitor prescribing in US emergency departments

3. Proton Pump Inhibitors and Risk of 1-Year Mortality and Rehospitalization in Older Patients Discharged From Acute Care Hospitals

4. Overprescribing proton pump inhibitors

5. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

2. Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges?;The AAPS Journal;2024-06-11

3. Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database;Neuro-Oncology Practice;2024-05-08

4. Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma multiforme: results from a nationwide real-world evidence database;2024-01-30

5. Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study;European Journal of Cancer;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3